Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.64M P/E - EPS this Y - Ern Qtrly Grth -
Income -1.14M Forward P/E 0.71 EPS next Y - 50D Avg Chg -27.00%
Sales 22.36M PEG - EPS past 5Y - 200D Avg Chg -69.00%
Dividend N/A Price/Book N/A EPS next 5Y 59.10% 52W High Chg -92.00%
Recommedations 2.00 Quick Ratio 0.03 Shares Outstanding 44.57M 52W Low Chg 22.00%
Insider Own 18.05% ROA -4.40% Shares Float 37.29M Beta 1.10
Inst Own 10.38% ROE - Shares Shorted/Prior 2M/439.68K Price 0.18
Gross Margin 23.28% Profit Margin -5.11% Avg. Volume 5,130,451 Target Price -
Oper. Margin -208.39% Earnings Date Oct 2 Volume 1,446,606 Change -8.29%
About Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquired pneumonia and ventilator associated pneumonia. The company is also developing AR-320, a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR 501, an inhaled gallium citrate, which is in Phase 1/2a for the treatment of chronic lung infection associated with cystic fibrosis; and AR-101, a human IgM mAb, which is in Phase II clinical trials targeting Pseudomonas aeruginosa liposaccharides serotype O11. In addition, it develops AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-701, a cocktail of two fully human immunoglobulin 1. The company was founded in 2003 and is headquartered in Los Gatos, California.

ARDS Chatroom

User Image Phaaisatroll Posted - 3 days ago

$ARDS published some days ago. Armistice owns 5 million shares. Did they buy them at the expert market for nearly nothing? Anyway that's a bullish move.

User Image xersdave Posted - 1 week ago

$ARDS So……

User Image Occitania Posted - 1 week ago

$ARDS Thanks...Idiot

User Image ReturnOfEsquire Posted - 10/31/24

$ARDS Whatever happens here, biotechs that have no cash are a terrible investment. Lesson learned...

User Image BostonDave Posted - 10/25/24

$ARDS We’re alive! Thanks for your inquiry. We are working diligently on the two Phase 3 programs as stated in our last update. We continue to expect meaningful progress to occur in the 4th quarter and plan to provide an update as soon as definitive, material achievements are made on these programs. We thank you for your continued interest and support of the company. Regards, Vu Truong, CEO

User Image xersdave Posted - 10/23/24

$ARDS So……??????

User Image BostonDave Posted - 1 month ago

$ARDS I have a small position in $ARDS in ETrade (with a large position at another brokerage). I looked at ETrade yesterday and saw that the value of ARDS in my account was up 10,000%. Somebody must be trading it over in the expert market.

User Image xersdave Posted - 1 month ago

$ARDS Well this is fun…

User Image phaa Posted - 2 months ago

$ARDS How could not laugh at Bobby buyout's posts A.K.A Phassisatroll? Keep posting you crack us all up ! Maybe they will give you a job Lol...

User Image BostonDave Posted - 2 months ago

$ARDS Thanks for your inquiry. We continue to make progress in our yearlong effort to monetize our clinical assets and platform technology. Due to the continued challenging capital market conditions in the past two years, we have temporarily prioritized the allocation of available resources to asset monetization efforts over financial audits and regulatory filings. As such we have intentionally delayed the filing of the 10-K and 10-Q until early Fall. We are actively completing our financial audits and regulatory filings in order to transfer back to the OTCQB market. Sincerely, Aridis Pharmaceuticals

User Image Phaaisatroll Posted - 2 months ago

$ARDS two weeks ago i send a message to Aridis regarding the potential investigation at AstraZeneca. Today i got a reply from Rebecca Edwards that she will forward it to Vu Truong. At least somebody is still working. Good to know.

User Image Phaaisatroll Posted - 2 months ago

$ARDS why is AstraZeneca sending me emails like this? Only because i uncovered their criminal behavior regarding Aridis i am now a valued member of their Talent Pool? Soon they will hire me i guess😅 So i don't publish this story everywhere.

User Image xersdave Posted - 2 months ago

$ARDS Watching paint dry….if nothing by EOY, this puppy is DONE. Hope not.

User Image FROGGER111 Posted - 2 months ago

$ARDS how much cash on hand?

User Image Phaaisatroll Posted - 2 months ago

$ARDS AR-501 is our trump card. Only 1 trial necessary to get approval. The drug in big pharma hands should easily make $300 million per year. Looking at the Cystic fibrosis foundation's pipeline of drugs we can still see AR-501 but they also supported Arikayce from Insmed which will generate revenue of over $300 million in 2024. Insmed market cap is now around $12 billion.

User Image arecki Posted - 2 months ago

@Shane65 sure, perhaps why you comment on CDT forum rather than on your investment's forum $ARDS? are you just a good samaritan with a warning?

User Image Phaaisatroll Posted - 2 months ago

$ARDS the people who developed AR-501 are still publishing research regarding Gallium. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11352784/

User Image GansoManso Posted - 2 months ago

$ARDS The mafia broker banks, along with the dirty hedge funds and investment banks, have taken your money. And this company's execs helped them do it. "... this really should be front page news, but the banks and brokers have big marketing budgets, so i imagine there will be very little coverage on this important news for investors in North America." The SEC was created and is controlled by the mafia broker banks, so don't expect them to do anything. Musk aptly dubbed them the "Short-Sellers Enrichment Commission". The only way to win is to stop playing their game. Instead, invest in ammo... not the ticker. https://finance.yahoo.com/news/end-naked-short-selling-230100677.html?guce_referrer=aHR0cHM6Ly93d3cuYmluZy5jb20v&guce_referrer_sig=AQAAAEg4_ra_uhbMoBbyVjhIRSOJqSlvjmByE_BwR27RFFtzghYSYnV9THkf-j7qc_AwjgcoWD1euIBQWwGKdNUtBpSmzFu6TarMAnOdbh6t4UQ9Lm4ojf6uamskgwhQy4Ct-0gfx19CCq-8-aLzLZrY5Cd5bL9RAveuQ1NEMKWSttF0&_guc_consent_skip=1725146611

User Image Phaaisatroll Posted - 08/28/24

$ARDS maybe somebody will realize the value of Aridis.

User Image Occitania Posted - 08/22/24

$ARDS https://www.tipranks.com/stocks/ards/insider-trading

User Image Rockyjs2 Posted - 3 months ago

$ARDS so this mess is 100% dead or do we have a chance at coming back? I have a small 200 shares that won’t worth selling. So it’ll sit until it goes completely under or pops. Whichever comes first

User Image Occitania Posted - 3 months ago

$ARDS

User Image NVDAMillionaire Posted - 3 months ago

$ARDS Aridis Pharmaceuticals, Inc. (ARDS): A Promising Biotech Tackling Antibiotic Resistance http://beyondspx.com/2024/08/02/aridis-pharmaceuticals-inc-ards-a-promising-biotech-tackling-antibiotic-resistance/

User Image kotatsu Posted - 3 months ago

$ARDS Yes, they have some promising assets.

User Image Phaaisatroll Posted - 3 months ago

$ARDS also with kinda zero trading ongoing right now nobody can try a hostile takeover. If somebody wants the company they have to go to Aridis and negotiate. And it seems like there are a lot of interested companies. Some are interested in the new technology Aridis was working on, some are interested in AR-501, AR-301 or AR-320. So if there's one company that makes a good offer for the whole company then this company could steal the assets from the other interested companies.

User Image Phaaisatroll Posted - 3 months ago

$ARDS the good results of AR-501 triggered business development discussions. So the 3 main assets are all in potential partnership discussions. Wondering why they never use the word buyout or M&A even though its clear that this could be a potential solution.

User Image Phaaisatroll Posted - 07/29/24

$ARDS in Q4 of last year i got this from an employee of Aridis. Hopefully that will also help to get good news this year.

User Image BostonDave Posted - 07/25/24

$ARDS Aridis spokesperson just responded to my inquiry about the SEC filings. They indicated that they will file in the Fall, with the delay owing to their ongoing financial issues.

User Image Occitania Posted - 07/25/24

$ARDS https://www.sec.gov/ix?doc=/Archives/edgar/data/1614067/000149315224025437/form8-k.htm

User Image Occitania Posted - 07/25/24

$ARDS

Analyst Ratings
HC Wainwright & Co. Buy Nov 6, 23
HC Wainwright & Co. Buy Oct 20, 23
HC Wainwright & Co. Buy Jan 26, 23
Maxim Group Hold Aug 16, 22
HC Wainwright & Co. Buy Jul 20, 21
HC Wainwright & Co. Buy May 15, 20
Roth Capital Buy Feb 19, 20
HC Wainwright & Co. Buy Dec 30, 19
Northcoast Research Outperform Sep 10, 18